Cargando…

Nardosinone Alleviates Parkinson's Disease Symptoms in Mice by Regulating Dopamine D2 Receptor

Nardostachyos Radix et Rhizoma (nardostachys) is the root and rhizome of Nardostachys jatamansi DC. Recent studies have shown that nardostachys may exert an anti-PD effect. In this study, the UHPLC-LTQ-Orbitrap-MS method was used to analyze the brain components of nardostachys in rats. Based on the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bian, Li-hua, Yao, Zi-wei, Zhao, Cheng-bowen, Li, Qiu-yu, Shi, Jin-li, Guo, Jian-you
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380167/ https://www.ncbi.nlm.nih.gov/pubmed/34426745 http://dx.doi.org/10.1155/2021/6686965

Ejemplares similares

Degradation Profiling of Nardosinone at High Temperature and in Simulated Gastric and Intestinal Fluids
por: Xue, Bian-Xia, et al.
Publicado: (2023)

Analysis of In Vivo Existence Forms of Nardosinone in Mice by UHPLC-Q-TOF-MS Technique
por: Zhang, Jing, et al.
Publicado: (2022)

Nardosinone Improves the Proliferation, Migration and Selective Differentiation of Mouse Embryonic Neural Stem Cells
por: Li, Ze-Hui, et al.
Publicado: (2014)

Dopamine D2 Receptor Is Involved in Alleviation of Type II Collagen-Induced Arthritis in Mice
por: Lu, Jian-Hua, et al.
Publicado: (2015)

Nardosinone Suppresses RANKL-Induced Osteoclastogenesis and Attenuates Lipopolysaccharide-Induced Alveolar Bone Resorption
por: Niu, Chenguang, et al.
Publicado: (2017)

Dopamine D2 receptors in the dorsomedial prefrontal cortex modulate social hierarchy in male mice
por: Li, Lai-Fu, et al.
Publicado: (2022)

Dopamine Receptors and Parkinson's Disease
por: Hisahara, Shin, et al.
Publicado: (2011)

Sinomenine activates astrocytic dopamine D2 receptors and alleviates neuroinflammatory injury via the CRYAB/STAT3 pathway after ischemic stroke in mice
por: Qiu, Jing, et al.
Publicado: (2016)

Dopamine-Induced Nonmotor Symptoms of Parkinson's Disease
por: Park, Ariane, et al.
Publicado: (2011)

Dopamine and dopamine receptor D1 as a novel favourable biomarker for hepatocellular carcinoma
por: Wang, Zhihui, et al.
Publicado: (2021)

Beyond Dopamine: GABA, Glutamate, and the Axial Symptoms of Parkinson Disease
por: O'Gorman Tuura, Ruth L., et al.
Publicado: (2018)

Gastrointestinal Symptoms and Dopamine Transporter Asymmetry in Early Parkinson's Disease
por: Murtomäki, Kirsi, et al.
Publicado: (2022)

Enhanced Dopamine Transmission and Hyperactivity in the Dopamine Transporter Heterozygous Mice Lacking the D3 Dopamine Receptor
por: Sotnikova, Tatyana D., et al.
Publicado: (2020)

Dopamine D3 receptor signaling alleviates mouse rheumatoid arthritis by promoting Toll-like receptor 4 degradation in mast cells
por: Wang, Biao, et al.
Publicado: (2022)

Dopamine D1 + D3 receptor density may correlate with parkinson disease clinical features
por: Yang, Pengfei, et al.
Publicado: (2020)

Untangling dopamine-adenosine receptor-receptor assembly in experimental parkinsonism in rats
por: Fernández-Dueñas, Víctor, et al.
Publicado: (2015)

Methamphetamine Increases Locomotion and Dopamine Transporter Activity in Dopamine D5 Receptor-Deficient Mice
por: Hayashizaki, Seiji, et al.
Publicado: (2013)

The Dopamine Receptor D3 Regulates Lipopolysaccharide-Induced Depressive-Like Behavior in Mice
por: Wang, Jing, et al.
Publicado: (2018)

Involvement of dopamine D3 receptor and dopamine transporter in methamphetamine‐induced behavioral sensitization in tree shrews
por: Huang, Jian, et al.
Publicado: (2020)

Behavioral characteristics of dopamine D(5) receptor knockout mice
por: Sasamori, Hitomi, et al.
Publicado: (2022)

Lycium barbarum polysaccharide improves dopamine metabolism and symptoms in an MPTP-induced model of Parkinson’s disease
por: Song, Jiangbo, et al.
Publicado: (2022)

Loss of NMDA receptors in dopamine neurons leads to the development of affective disorder-like symptoms in mice
por: Jastrzębska, Kamila, et al.
Publicado: (2016)

Dopamine D3 Receptor Plasticity in Parkinson’s Disease and L-DOPA-Induced Dyskinesia
por: Lanza, Kathryn, et al.
Publicado: (2021)

Regulation Mechanism of Dopamine Receptor 1 in Low Temperature Response of Marsupenaeus japonicus
por: Ren, Xianyun, et al.
Publicado: (2023)

Regulation of Cdc42 signaling by the dopamine D2 receptor in a mouse model of Parkinson’s disease
por: Ying, Li, et al.
Publicado: (2022)

Dopamine Receptor Autoantibodies Correlate with Symptoms in Sydenham's Chorea
por: Ben-Pazi, Hilla, et al.
Publicado: (2013)

Dopamine agonists in Parkinson’s disease: Impact of D1-like or D2-like dopamine receptor subtype selectivity and avenues for future treatment
por: Isaacson, Stuart H., et al.
Publicado: (2023)

Delayed Dopamine Dysfunction and Motor Deficits in Female Parkinson Model Mice
por: Chen, Yuan-Hao, et al.
Publicado: (2019)

Berberine alleviates symptoms of anxiety by enhancing dopamine expression in rats with post-traumatic stress disorder
por: Lee, Bombi, et al.
Publicado: (2018)

Genetic labeling reveals temporal and spatial expression pattern of D2 dopamine receptor in rat forebrain
por: Yu, Qing, et al.
Publicado: (2019)

Acupuncture Alleviated the Nonmotor Symptoms of Parkinson's Disease including Pain, Depression, and Autonomic Symptoms
por: Iseki, Chifumi, et al.
Publicado: (2014)

Dopamine-Depleted Dopamine Transporter Knockout (DDD) Mice: Dyskinesia with L-DOPA and Dopamine D1 Agonists
por: Pogorelov, Vladimir M., et al.
Publicado: (2023)

Intracerebroventricular dopamine for Parkinson's disease
por: Devos, David, et al.
Publicado: (2017)

Predictors of dopamine dysregulation syndrome in patients with early Parkinson’s disease
por: Liang, Keke, et al.
Publicado: (2023)

Subthalamic beta bursts correlate with dopamine-dependent motor symptoms in 106 Parkinson’s patients
por: Lofredi, Roxanne, et al.
Publicado: (2023)

Implication of dopamine D3 receptor activation in the reversion of Parkinson's disease-related motivational deficits
por: Carnicella, S, et al.
Publicado: (2014)

Occupancy of pramipexole (Sifrol) at cerebral dopamine D2/3 receptors in Parkinson's disease patients
por: Deutschländer, Angela, et al.
Publicado: (2016)

Chronic exposure to dopamine agonists affects the integrity of striatal D(2) receptors in Parkinson's patients
por: Politis, Marios, et al.
Publicado: (2017)

Developing Photoaffinity Probes for Dopamine Receptor D(2) to Determine Targets of Parkinson’s Disease Drugs
por: Kim, Spencer T., et al.
Publicado: (2022)

Retinal Dopamine D2 Receptors Participate in the Development of Myopia in Mice
por: Huang, Furong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5tl1kp864o499jil4oeh8133jg